Ursodeoxycholic acid (UDCA) ( DrugBank: Ursodeoxycholic acid, UDCA )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
94	原発性硬化性胆管炎	4

94. 原発性硬化性胆管炎

臨床試験数 : 148 / 薬物数 : 118 - (DrugBank : 39) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 141

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03678480 (ClinicalTrials.gov)	March 1, 2021	18/9/2018	A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)	A Phase 2, Randomized, Double-Blind Study of HTD1801 vs Ursodeoxycholic Acid (UDCA)in Adolescents Wi ...	Primary Sclerosing Cholangitis;Cholangitis;Cholangitis, Sclerosing;Bile Duct Diseases;Biliary Tract ...	Drug: HTD1801;Drug: Ursodeoxycholic Acid	HighTide Biopharma Pty Ltd	NULL	Withdrawn	12 Years	17 Years	All	0	Phase 2	NULL
2	EUCTR2015-003310-24-SE (EUCTR)	09/10/2015	01/09/2015	Ursodeoxycholic Acid (UDCA)in Preventing Hepatobiliary and Colorectal Malignancy in Surveillance Pat ...	A Phase 3, Open-label, Randomized, Prospective Clinical Trial Evaluating the Efficacy of Stratified ...	Primary sclerosing cholangitis with or without concomitant inflammatory bowel disease included in an ...	Trade Name: Ursofalk Product Name: Ursofalk	Sahlgrenska Academy	NULL	Not Recruiting			Female: yes Male: yes	500	Phase 3	Sweden
3	NCT01456468 (ClinicalTrials.gov)	October 2011	14/10/2011	Combination Therapy With Ursodeoxycholic Acid (UDCA)and All-Trans Retinoic Acid (ATRA) for Treatment ...	Combination Therapy With Ursodeoxycholic Acid (UDCA)and All-Trans Retinoic Acid (ATRA) for Treatment ...	Cholangitis, Sclerosing	Drug: Oral all-trans retinoic acid (ATRA)	Yale University	Mayo Clinic	Completed	18 Years	80 Years	Both	19	Phase 1	United States
4	NCT01088607 (ClinicalTrials.gov)	October 2010	12/3/2010	Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangiti ...	Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinsti ...	Primary Sclerosing Cholangitis	Drug: ursodeoxycholic acid (UDCA)	University of Tennessee	Icahn School of Medicine at Mount Sinai;Ann & Robert H Lurie Children's Hospital of Chicago;Universi ...	Completed	5 Years	21 Years	All	27	Phase 1	United States;Canada

First Previous1Next Last